Docusign (NASDAQ:DOCU) Price Target Cut to $55.00 by Analysts at Royal Bank Of Canada

Docusign (NASDAQ:DOCU) had its target price lowered by Royal Bank Of Canada from $70.00 to $55.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has a sector perform rating on the stock.

A number of other research analysts also recently issued reports on DOCU. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a report on Wednesday, January 21st. JPMorgan Chase & Co. reduced their price objective on Docusign from $80.00 to $78.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Cantor Fitzgerald reissued an “outperform” rating on shares of Docusign in a research report on Wednesday, December 17th. Wells Fargo & Company lowered their target price on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, UBS Group dropped their price target on shares of Docusign from $75.00 to $54.00 and set a “neutral” rating on the stock in a report on Wednesday. Five research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $66.67.

Docusign Stock Up 2.9%

Shares of DOCU opened at $48.90 on Wednesday. Docusign has a twelve month low of $40.16 and a twelve month high of $94.67. The company has a market capitalization of $9.79 billion, a P/E ratio of 33.04, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The firm has a 50 day moving average of $50.69 and a 200 day moving average of $64.35.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a return on equity of 16.70% and a net margin of 9.60%.The business had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. During the same period in the prior year, the firm posted $0.86 EPS. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. On average, sell-side analysts expect that Docusign will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has approved a stock buyback program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to reacquire up to 21% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Transactions at Docusign

In other Docusign news, CFO Blake Jeffrey Grayson sold 6,500 shares of the firm’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $70.00, for a total value of $455,000.00. Following the transaction, the chief financial officer directly owned 111,713 shares of the company’s stock, valued at approximately $7,819,910. This trade represents a 5.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the sale, the executive owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This represents a 8.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 51,477 shares of company stock worth $3,521,607 in the last three months. 1.01% of the stock is owned by insiders.

Hedge Funds Weigh In On Docusign

A number of institutional investors and hedge funds have recently made changes to their positions in DOCU. Central Pacific Bank Trust Division bought a new stake in Docusign during the fourth quarter valued at approximately $25,000. Modus Advisors LLC bought a new position in Docusign in the fourth quarter worth approximately $27,000. Torren Management LLC bought a new position in Docusign in the fourth quarter worth approximately $28,000. Aventura Private Wealth LLC purchased a new position in shares of Docusign during the 4th quarter worth $30,000. Finally, True Wealth Design LLC boosted its stake in shares of Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.